Literature DB >> 10982079

Long-term persistence of Coxiella burnetii in the host after primary Q fever.

R J Harris1, P A Storm, A Lloyd, M Arens, B P Marmion.   

Abstract

After a primary infection Coxiella burnetii may persist covertly in animals and recrudesce at parturition to be shed in the products of conception and the milk. Similar latent persistence and recrudescence occurs in man: namely, infection of placenta, heart valve or mural endocardium, bone or liver. The numbers of organisms, their viability and cellular form, and the underlying organ sites of latent infection for the coxiella are obscure. During investigations of 29 patients with a chronic sequel to acute Q fever, the post-Q fever fatigue syndrome (QFS) [1-3], sensitive conventional and TaqMan-based PCR revealed low levels of C. burnetii DNA in blood mononuclear cells (5/29; 17%), thin needle liver biopsies (2/14; 14%) and, notably, in bone marrow aspirates (13/20; 65%). Irrespective of the ultimate significance of coxiella persistence for QFS, the detection of C. burnetii genomic DNA in bone marrow several years after a primary infection unveils a new pathological dimension for Q fever.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10982079      PMCID: PMC2810941          DOI: 10.1017/s0950268899003763

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  27 in total

1.  Endograft-preserving therapy of a patient with Coxiella burnetii-infected abdominal aortic aneurysm: a case report.

Authors:  Geoffrey Tl Kloppenburg; Eric Dwm van de Pavoordt; Jean-Paul Pm de Vries
Journal:  J Med Case Rep       Date:  2011-12-06

2.  Comparison of PCR and serology assays for early diagnosis of acute Q fever.

Authors:  Pierre-Edouard Fournier; Didier Raoult
Journal:  J Clin Microbiol       Date:  2003-11       Impact factor: 5.948

3.  A Q Fever Outbreak in the Netherlands: Consequences for Tissue Banking.

Authors:  Marja J van Wijk; Boris M Hogema; D Willemijn Maas; Arlinke G Bokhorst
Journal:  Transfus Med Hemother       Date:  2011-11-14       Impact factor: 3.747

4.  Serologic detection of a rare case of Q fever in New York City having hepatic and unusual renal complications.

Authors:  C S Pavia; C McCalla
Journal:  Infection       Date:  2010-04-08       Impact factor: 3.553

5.  Clinical and pathologic changes in a guinea pig aerosol challenge model of acute Q fever.

Authors:  K E Russell-Lodrigue; G Q Zhang; D N McMurray; J E Samuel
Journal:  Infect Immun       Date:  2006-11       Impact factor: 3.441

6.  Coxiella burnetii - Pathogenic Agent of Q (Query) Fever.

Authors:  Lutz Gürtler; Ursula Bauerfeind; Johannes Blümel; Reinhard Burger; Christian Drosten; Albrecht Gröner; Margarethe Heiden; Martin Hildebrandt; Bernd Jansen; Ruth Offergeld; Georg Pauli; Rainer Seitz; Uwe Schlenkrich; Volkmar Schottstedt; Johanna Strobel; Hannelore Willkommen
Journal:  Transfus Med Hemother       Date:  2013-12-23       Impact factor: 3.747

7.  Analysis of the Caenorhabditis elegans innate immune response to Coxiella burnetii.

Authors:  James M Battisti; Lance A Watson; Myo T Naung; Adam M Drobish; Ekaterina Voronina; Michael F Minnick
Journal:  Innate Immun       Date:  2016-11-24       Impact factor: 2.680

8.  Roles of Toll-Like Receptor 2 (TLR2), TLR4, and MyD88 during Pulmonary Coxiella burnetii Infection.

Authors:  Andrew G Ramstead; Amanda Robison; Anne Blackwell; Maria Jerome; Brett Freedman; Kirk J Lubick; Jodi F Hedges; Mark A Jutila
Journal:  Infect Immun       Date:  2016-03-24       Impact factor: 3.441

9.  Enterovirus related metabolic myopathy: a postviral fatigue syndrome.

Authors:  R J M Lane; B A Soteriou; H Zhang; L C Archard
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-10       Impact factor: 10.154

10.  Role for the CD28 molecule in the control of Coxiella burnetii infection.

Authors:  Amélie Honstettre; Soraya Meghari; Jacques A Nunès; Hubert Lepidi; Didier Raoult; Daniel Olive; Jean-Louis Mege
Journal:  Infect Immun       Date:  2006-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.